Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
This is the observational half of the National Institute of Arthritis and Musculoskeletal and Skin Diseases' clinical portfolio: studies that watch rather than intervene.
The title carries the hard condition, and it runs the other way from its sibling notice: a clinical trial is not allowed here. The institute publishes separate routes for exploratory and full trials.
The activity code is R01, N…
Clinical observational studies in musculoskeletal, rheumatic and skin diseases under NIH's standard research project grant. Interventional clinical trials are out of scope.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →Advanced Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the enhancement of a cancer informatics tool that has cleared prototyping, shows real promise, and has not yet been widely adopted.
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All
🇺🇸NIH · United States
Funds a single hub that coordinates data, evaluation and operations for a consortium of community-based oral health research projects.
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03)
🇺🇸NIH · United States
Funds one small self-contained project for a scholar already inside the Clinical and Translational Science Award network, on the way to a first full award.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
NIH · United States
Funds the move of an imaging-centred multimodal AI tool from a trained and tested prototype towards real clinical use, as regulated device software.
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data
NIH · United States
Funds a company and an academic team to build and test an imaging-centred multimodal AI decision tool, developed as software that is a medical device.
Sustained Support for Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the running costs and continued relevance of a cancer informatics tool that researchers already depend on.
Similar grants
Browse the directory →NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
🇺🇸FDA OOPD · United States
Funds natural-history studies that improve preparedness for rare disease trial pathways.
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
Preclinical Proof of Concept for Novel Recording/Modulation Technologies in Human CNS
🇺🇸BRAIN Initiative · United States
Funds preclinical testing for novel neural recording and modulation technologies before clinical transition.
DoW Orthopaedic, Clinical Research Award
🇺🇸MRDC / CDMRP · United States
Funds clinical research into combat orthopaedic injury at two levels — one observational, one requiring an actual clinical trial.
CFF Clinical Pilot and Feasibility Award
🇺🇸CFF · United States
Provides clinicians and translational researchers for CFF Clinical Pilot and Feasibility Award in biotechnology and medical technology.